Finance

Lists
BOLT:NASDAQ
Bolt Biotherapeutics Inc
$3.98
+0.89%
(+0.035) 1D
Aug 5, 1:46:31 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BOLT...
Open
$4.05
High
$4.05
Low
$3.98
Mkt. cap
7.66M
Avg. vol.
16.79K
Volume
1.95K
52-wk high
$7.09
52-wk low
$3.75
EPS
-$16.34
Beta
1.18
Shares outstanding
1.92M
No. of employees
23
Open
$4.05
High
$4.05
Low
$3.98
Mkt. cap
7.66M
Avg. vol.
16.79K
Volume
1.95K
52-wk high
$7.09
52-wk low
$3.75
EPS
-$16.34
Beta
1.18
Shares outstanding
1.92M
No. of employees
23
News stories
From sources across the web
About Bolt Biotherapeutics Inc
CEO-
Employees23
Founded2015
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websiteboltbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to BOLT in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BOLT in the last 3 months.
Highest
Current $3.98
$75.00 (+1,782.06%)
Average
$34.67 (+770.01%)
Lowest
$7.00 (+75.66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Hold
Maintained
-
-
06/25/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$22.00
+452.1%
05/28/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$7.00
+75.7%
05/28/2026
Chad Messer
Lake Street
Buy
Maintained
$75.00
+1,782.1%
05/13/2026
Unknown Analyst
JonesTrading
Hold
Maintained
-
-
04/06/2026
Next call in 7 days
Wed, Aug 12, 10:00 PM
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -$21.06
Revenue / Est. (USD)
- / 500.00K
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.80M
2.17M
2.50M
26.00K
Cost of goods sold
7.50M
6.54M
4.99M
4.59M
Cost of revenue
7.50M
6.54M
4.99M
4.59M
Research and development expenses
-
-
-
242.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.52M
3.34M
3.12M
2.80M
Operating expense
3.52M
3.34M
3.12M
3.04M
Total operating expenses
11.01M
9.87M
8.10M
7.63M
Operating income
-9.21M
-7.70M
-5.60M
-7.60M
Other non operating income
50.00K
82.00K
87.00K
81.00K
EBT including unusual items
-8.56M
-7.14M
-6.63M
-7.24M
EBT excluding unusual items
-8.56M
-7.14M
-5.15M
-7.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.56M
-7.14M
-6.63M
-7.24M
Net profit margin
-474.56%
-329.37%
-265.24%
-27,861.54%
Earnings per share
-4.46
-3.72
-2.98
-4.31
Interest and investment income
599.00K
477.00K
367.00K
276.00K
Interest expense
-
-
-
-
Net interest expenses
599.00K
477.00K
367.00K
276.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.86M
-7.41M
-5.35M
-7.40M
Gain or loss from assets sale
-
-
-
-31.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps